Print
22 January 2016
PitchBook Blog
The last couple years have seen two peaks for the European venture capital industry, as illustrated in our 2015 Annual European Venture Industry Report. The first was in activity, with just over 3,400 rounds closed in 2014 for a massive €9.3 billion tally—the second was a simply staggering €12.9 billion in VC invested during 2015, even as the number of rounds plummeted from the heights of the prior year. To examine the trends behind such mammoth sums, and expand our coverage of European venture capital in general, we have split our prior European PE & VC Breakdown into two separate reports. |
|
This 2015 Annual European Venture Industry Report, sponsored by Merrill DataSite, accordingly contains many more datasets on European venture financing, including:
There is much more within the report, so access it for free by clicking here. |
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.